https://orcid.org/0000-0002-2674-3705
References
- Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–350. doi:10.1038/nature1581726469045
- Owusu-Obeng A, Weitzel KW, Hatton RC, et al. Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacother. 2014;34(10):1102–1112. doi:10.1002/phar.1481
- Relling MV, Klein TE, Gammas RS, Whirl-Carrillo M, Hoffman J, Caudle KE. The Clinical Pharmacogenetics Implementation Consortium: 10 years later. Clin Pharmacol Ther. 2020;107(1):171–175. doi:10.1002/cpt.165131562822
- Hoffman JM, Dunnenberger HM, Hicks JK, et al. Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC). J Am Med Inform Assoc. 2016;23(4):796–801. doi:10.1093/jamia/ocw02727026620
- Hilden MP, Bright DR, Kisor DF, Christensen H. Pharmacogenomics: a practical primer for senior care pharmacists. Sr Care Pharm. 2019;34(6):363–369. doi:10.4140/TCP.n.2019.36331164183
- Food and Drug Administration. FDA announces collaborative review of scientific evidence to support associations between genetic information and specific medications; 2 2020 Available from: https://www.fda.gov/news-events/press-announcements/fda-announces-collaborative-review-scientific-evidence-support-associations-between-genetic. Accessed 84, 2020.
- Bright DR, Greco AJ, Langerveld A, Kisor DF. Clinical implementation of personalized medicine in community pharmacies: considerations for clinicians. Per Med. 2017;14(6):471–475. doi:10.2217/pme-2017-005029749860
- Food and Drug Administration. Table of pharmacogenetic associations; 2 2020 Available from: https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations. Accessed 83, 2020.
- Clinical Pharmacogenetics Implementation Consortium. Guidelines; 7 2019 Available from: http://www.cpicpgx.org/guidelines. Accessed 83, 2020.
- Frigon M-P, Blackburn M-È, Dubois-Bouchard C, Gagnon A-L, Tardif S, Tremblay K. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics. 2019;20(8):589–598. doi:10.2217/pgs-2019-000431190623
- Kim W-Y, Kim H-S, Oh M, Shin J-G. Survey of physicians’ views on the clinical implementation of pharmacogenomics-based personalized therapy. Trans Clin Pharmacol. 2020;28(1):34–42. doi:10.12793/tcp.2020.28.e6
- Owusu Obeng A, Fei K, Levy K, et al. Physician-reported benefits and barriers to clinical implementation of genomic medicine: a multi-site IGNITE-network survey. J Pers Med. 2018;8(3):24. doi:10.3390/jpm8030024
- Bank PCD, Swen JJ, Schaap RD, et al. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care. Eur J Hum Genet. 2019;27(10):1532–1541. doi:10.1038/s41431-019-0454-x31227807
- American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacogenomics. Am J Health Syst Pharm. 2015;72(7):579–581. doi:10.2146/sp15000325788513
- Bain KT, Schwartz EJ, Knowlton OV, Knowlton CH, Turgeon J. Implementation of a pharmacist-led pharmacogenomics service for the program of all-inclusive care for the elderly (PHARM-GENOME-PACE). J Am Pharm Assoc. 2018;58(3):281–289. doi:10.1016/j.japh.2018.02.011
- Empey PE, Stevenson JM, Tuteja S, et al. Multisite investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy. Clin Pharmacol Ther. 2018;104(4):664–674. doi:10.1002/cpt.100629280137
- Hicks JK, Aquilante C, Dunnenberger HM, et al. Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice. J Am Coll Clin Pharm. 2019;2(3):303–313. doi:10.1002/jac5.111832984775